A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R

NCT07513649 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Participants

Interventions

DRUG: DA-5230
DRUG: DA-5230-R

Sponsor

Dong-A ST Co., Ltd.